Unknown

Dataset Information

0

A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia.


ABSTRACT: Antipsychotic (AP) drugs are used to treat psychiatric disorders but are associated with significant weight gain and metabolic disease. Increased food intake (hyperphagia) appears to be a driving force by which APs induce weight gain but the mechanisms are poorly understood. Here we report that administration of APs to C. elegans induces hyperphagia by a mechanism that is genetically distinct from basal food intake. We exploit this finding to screen for adjuvant drugs that suppress AP-induced hyperphagia in C. elegans and mice. In mice AP-induced hyperphagia is associated with a unique hypothalamic gene expression signature that is abrogated by adjuvant drug treatment. Genetic analysis of this signature using C. elegans identifies two transcription factors, nhr-25/Nr5a2 and nfyb-1/NFYB to be required for AP-induced hyperphagia. Our study reveals that AP-induced hyperphagia can be selectively suppressed without affecting basal food intake allowing for novel drug discovery strategies to combat AP-induced metabolic side effects.

SUBMITTER: Perez-Gomez A 

PROVIDER: S-EPMC6288085 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia.

Perez-Gomez Anabel A   Carretero Maria M   Weber Natalie N   Peterka Veronika V   To Alan A   Titova Viktoriya V   Solis Gregory G   Osborn Olivia O   Petrascheck Michael M  

Nature communications 20181210 1


Antipsychotic (AP) drugs are used to treat psychiatric disorders but are associated with significant weight gain and metabolic disease. Increased food intake (hyperphagia) appears to be a driving force by which APs induce weight gain but the mechanisms are poorly understood. Here we report that administration of APs to C. elegans induces hyperphagia by a mechanism that is genetically distinct from basal food intake. We exploit this finding to screen for adjuvant drugs that suppress AP-induced hy  ...[more]

Similar Datasets

| S-EPMC4267929 | biostudies-literature
| S-EPMC3585123 | biostudies-literature
| S-EPMC4197881 | biostudies-other
| S-EPMC4978917 | biostudies-literature
| S-EPMC5837500 | biostudies-literature
| S-EPMC5736127 | biostudies-literature
| S-EPMC4856098 | biostudies-literature
2023-05-30 | PXD027733 | Pride
| S-EPMC7426821 | biostudies-literature
| S-EPMC10473659 | biostudies-literature